Latest Articles

Publication Date
SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair | Oncogenesis - Nature.com

SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair | Oncogenesis Nature.com

Published: Jan. 8, 2024, 8 a.m.
Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million - Business Wire

Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 Million Business Wire

Published: Jan. 8, 2024, 8 a.m.
Lesser Studied Pathologies – January 5, 2024 - National Institutes of Health (NIH) (.gov)

Lesser Studied Pathologies – January 5, 2024 National Institutes of Health (NIH) (.gov)

Published: Jan. 5, 2024, 8 a.m.
Luteolin attenuates Staphylococcus aureus -induced endometritis through inhibiting ferroptosis and inflammation via activating the Nrf2/GPX4 signaling pathway - American Society for Microbiology

Luteolin attenuates Staphylococcus aureus -induced endometritis through inhibiting ferroptosis and inflammation via activating the Nrf2/GPX4 signaling pathway American Society for Microbiology

Published: Jan. 3, 2024, 8 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!